FDA Gets Mixed Advice on Nanotechnology
October 10th, 2006(AP) -- The government must balance close oversight of the fast-growing field of nanotechnology against the risk of stifling new development, a Food and Drug Administration conference was told Tuesday.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Experts argue nano food-additives require new oversight
Dec 18, 2008 |
4.7 / 5 (3) |
1
Consumers call for more government oversight of commercial genetic tests
Jul 07, 2008 |
3.7 / 5 (3) |
0
Nanotech safety high on Congress' priority list
Jan 16, 2009 |
4 / 5 (1) |
0
Merck's heart failure drug misses trial goals
Jun 05, 2009 |
not rated yet |
1
Off-label use of stents investigated
Mar 07, 2007 |
4 / 5 (1) |
0

